Randomized, Single-dose, Parallel-arm, Open-label Phase I Trial to Investigate and Compare the Pharmacokinetics, Safety and Tolerability of BI 695501 Administered Subcutaneously Via Prefilled Syringe or Autoinjector

Trial Profile

Randomized, Single-dose, Parallel-arm, Open-label Phase I Trial to Investigate and Compare the Pharmacokinetics, Safety and Tolerability of BI 695501 Administered Subcutaneously Via Prefilled Syringe or Autoinjector

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease; Plaque psoriasis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Acronyms VOLTAIRE-AI
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
    • 08 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2016 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top